Results 11 to 20 of about 3,970 (233)

The therapeutic value of cerebrospinal fluid ctDNA detection by next-generation sequencing for meningeal carcinomatosis: a case report [PDF]

open access: goldBMC Neurology, 2019
Background It is usually very complicated to treat meningeal carcinomatosis, and it is important to treat it as soon as possible. Case presentation The 19-Del mutation was found in the exon for the epidermal growth factor receptor gene in the pleural ...
Xiaosu Guo   +9 more
doaj   +4 more sources

Meningeal carcinomatosis in solid tumors [PDF]

open access: goldArquivos de Neuro-Psiquiatria, 2011
The involvement of the leptomeninges by metastatic tumors can be observed in solid tumors, in which case it is termed meningeal carcinomatosis (MC), and in lymphoproliferative malignant disease.
Sandro José Martins   +5 more
doaj   +6 more sources

Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal Carcinomatosis. [PDF]

open access: goldBreast J
Purpose: Meningeal carcinomatosis (MC) has a dismal prognosis in patients with breast cancer and requires invasive therapies. The aim of the present retrospective study was to determine a prognostic score for overall survival (OS) in patients with breast cancer and treated for MC.
Narjoux G   +9 more
europepmc   +4 more sources

Meningeal Carcinomatosis for Prostate Adenocarcinoma Mimicking Chronic Subdural Hematoma: Case Report and Literature Review [PDF]

open access: diamondBrazilian Neurosurgery, 2021
Introduction Cerebral metastases are the most common cancer of the central nervous system (CNS). Meningeal infiltration by neoplasms that did not originate in the CNS is a rare fact that is present in 0.02% of the autopsies.
Tiago Silva Holanda Ferreira   +4 more
doaj   +2 more sources

Sensorineural Hearing Loss as the Prominent Symptom in Meningeal Carcinomatosis [PDF]

open access: yesCurrent Oncology, 2021
Sensorineural hearing loss (SNHL) has been reported rarely in patients with meningeal carcinomatosis (MC). We summarized the clinical data of eight MC patients with SNHL and 35 patients reported from publications.
Xiaoqin Huang, Yu Jia, Lidong Jiao
doaj   +2 more sources

Meningeal carcinomatosis and blindness [PDF]

open access: bronzeJournal of Neurology, Neurosurgery & Psychiatry, 1973
The clinical syndrome of meningeal carcinomatosis includes headache, dementia, radiculopathy, and cranial nerve palsies. Blindness may be the first, or most prominent, symptom. When blindness occurs in adult life, meningeal carcinomatosis should be included in the differential diagnosis, even in the absence of other symptoms and in the absence of known
P H, Altrocchi, P B, Eckman
openaire   +4 more sources

Bilateral Vocal Cord Paralysis Associated with Meningeal Carcinomatosis from Lung Adenocarcinoma [PDF]

open access: yesCase Reports in Neurology, 2022
Cranial neuropathy is a clinical manifestation of meningeal carcinomatosis (MC); however, the glossopharyngeal and vagus nerves are rarely impaired. Therefore, dysphagia and bilateral vocal cord paralysis (BVCP) are extremely rare manifestations of MC ...
Gohei Yamada   +3 more
doaj   +2 more sources

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response [PDF]

open access: yesBMC Cancer, 2017
Background Non-muscle invasive bladder cancer (NMIBC) is usually treated with local therapy including transurethral resection of the bladder tumor and intravesical therapy depending on the stage of the tumor.
Diego Teyssonneau   +5 more
doaj   +2 more sources

Intrathecal Therapy Options for Meningeal Carcinomatosis. [PDF]

open access: yesGeburtshilfe Frauenheilkd
Around 5 percent of all patients with metastatic breast cancer go on to develop distant metastases in the meninges, also known as meningeal carcinomatosis. The median survival of these patients is between 3.5 and 4.5 months.
Marowsky M   +5 more
europepmc   +2 more sources

Response of Meningeal Carcinomatosis from Breast Cancer to Capecitabine Monotherapy: A Case Report [PDF]

open access: yesCase Reports in Oncology, 2013
A 62-year-old woman with breast cancer received neoadjuvant chemotherapy followed by breast-conserving surgery and sentinel node biopsy. During adjuvant endocrine therapy with aromatase inhibitor, she developed multiple bone metastases.
Yumi Tanaka   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy